Why Centrus Energy Stock Crashed 26% in October

Limping toward the end of 2026, Centrus Energy (LEU +17.49%) stock fell 18.6% in September and continued to decline last month. Analysts took a more bearish stance on the nuclear stock, and investors were clearly paying attention.

According to data provided by S&P Global Market Intelligence, Centrus Energy stock fell 26% in October, while the S&P 500 dipped 0.5%.

On Oct. 19, Centrus announced its acquisition of Westerman Holdings, which the company characterizes as one of its largest and most diversified suppliers. Centrus believes that the transaction, funded with about $95 million in cash and $21 million in equity, will contribute to its adjusted earnings per share in the first year following its closing.

NYSE · As of 4:00 PM ET 11/06/26

Centrus lauded the acquisition as "a significant milestone ... as it builds supply chain resilience while diversifying its revenue base." Westerman provides Centrus to a variety of industries beyond nuclear, including oil and gas and other industrial sectors.

Investors immediately expressed their disapproval of the acquisition. Centrus shares dropped more than 4% on Oct. 19 from the stock's previous close.

On Oct. 20, analysts began to weigh in on the acquisition -- and the opinions were hardly encouraging. Roth Capital slashed its price target on Centrus to $115 from $188, maintaining a neutral rating. According to Thefly.com, the firm updated its model after Centrus acquired Westerman Holdings and believes that the company's third-quarter financial results could disappoint investors.

In the ensuing days, firms shared a variety of other downwardly revised price targets.

Centrus is a leading provider of nuclear fuel and services for the nuclear power industry. One area in which the company distinguishes itself is the production of high-assay low-enriched uranium (HALEU), a specialized form of nuclear fuel required by small modular reactors (SMRs), the next generation of nuclear reactors. At the end of September 2026, Centrus reported a backlog of $5.4 billion for both low-enriched uranium (LEU) and HALEU businesses.

While firms may have soured on Centrus stock due to its acquisition of Westerman, long-term investors should hardly follow their lead. The company has a robust competitive advantage in its nuclear fuel production capabilities, which should serve it well as the nuclear energy renaissance continues to take shape. For those seeking a leading nuclear energy stock, Centrus remains a worthwhile consideration.